Related Experiment Video
Updated: Mar 2, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline
Artyom A Alekseyenko1,2, Erica M Walsh3, Barry M Zee1,2
1Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Abstract:
To investigate the mechanism that drives dramatic mistargeting of active chromatin in NUT midline carcinoma (NMC), we have identified protein interactions unique to the BRD4-NUT fusion oncoprotein compared with wild-type BRD4. Using cross-linking, affinity purification, and mass spectrometry, we identified the EP300 acetyltransferase as uniquely associated with BRD4 through the NUT fusion in both NMC and non-NMC cell types. We also discovered ZNF532 associated with BRD4-NUT in NMC patient cells but not detectable in 293T cells. EP300 and ZNF532 are both implicated in feed-forward regulatory loops leading to propagation of the oncogenic chromatin complex in BRD4-NUT patient cells. Adding key functional significance to our biochemical findings, we independently discovered a ZNF532-NUT translocation fusion in a newly diagnosed NMC patient. ChIP sequencing of the major players NUT, ZNF532, BRD4, EP300, and H3K27ac revealed the formation of ZNF532-NUT-associated hyperacetylated megadomains, distinctly localized but otherwise analogous to those found in BRD4-NUT patient cells. Our results support a model in which NMC is dependent on ectopic NUT-mediated interactions between EP300 and components of BRD4 regulatory complexes, leading to a cascade of misregulation.
Insights
NUT midline carcinoma (NMC) involves mistargeted chromatin due to BRD4-NUT fusion proteins. This study identifies EP300 and ZNF532 as key interactors, revealing a mechanism driving oncogenic complex propagation in NMC.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- NUT midline carcinoma (NMC) is driven by oncogenic fusion proteins.
- The precise mechanisms of chromatin dysregulation in NMC are not fully understood.
Purpose of the Study:
- To investigate the protein interactions and molecular mechanisms underlying chromatin mistargeting in NMC.
- To identify unique interactions of the BRD4-NUT fusion oncoprotein.
Main Methods:
- Cross-linking, affinity purification, and mass spectrometry were used to identify protein interactions.
- Chromatin immunoprecipitation (ChIP) sequencing was performed to analyze the localization of key proteins and histone modifications.
- Biochemical and genetic approaches were employed to study the functional significance of identified interactions.
Main Results:
- EP300 acetyltransferase was identified as uniquely associated with BRD4 through the NUT fusion.
- ZNF532 was found associated with BRD4-NUT in NMC patient cells.
- A ZNF532-NUT translocation fusion was discovered, forming hyperacetylated megadomains analogous to BRD4-NUT.
- These proteins are implicated in feed-forward regulatory loops propagating the oncogenic chromatin complex.
Conclusions:
- NMC pathogenesis involves ectopic NUT-mediated interactions between EP300 and BRD4 regulatory complexes.
- This interaction leads to a cascade of chromatin misregulation and supports a model of NMC dependency on these aberrant complexes.
More Related Videos
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic...
Canonical Wnt Signaling Pathway
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...